Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$5,266,970
-$674,280 QoQ
Shares Held
218,728
+3.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#583
of 2,821 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allen Capital Group, LLC holds $17,687,025 across 8 Drug Manufacturers - General names. PFE ranks #1 (29.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
This page
|
218,728 | $5,266,970 | |
| 2 | NVO |
Novo Nordisk A S
|
76,530 | $3,668,848 | |
| 3 | JNJ |
Johnson & Johnson
|
12,012 | $3,050,687 | |
| 4 | LLY |
ELI LILLY & Co
|
2,102 | $2,521,202 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,589 | $1,360,686 | |
| 6 | ABBV |
AbbVie Inc.
|
3,915 | $985,170 | |
| 7 | AMGN |
Amgen Inc
|
1,428 | $517,107 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,504 | $316,355 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,266,970 | 218,728 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $5,941,250 | 211,583 | Shares | Sole | 2026-05-27 | |
| 2025-12-31 | $4,886,276 | 196,236 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,753,243 | 186,548 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $4,101,044 | 169,185 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,624,532 | 143,036 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $3,331,690 | 125,582 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $3,296,873 | 113,921 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,920,412 | 104,375 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,880,144 | 103,789 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $3,102,352 | 107,758 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $2,242,723 | 67,613 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $2,405,731 | 65,587 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $2,506,058 | 61,423 | Shares | Sole | 2023-04-28 | |
| 2022-09-30 | $1,917,782 | 43,825 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,188,375 | 41,739 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,119,670 | 40,944 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $2,337,966 | 39,593 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,695,497 | 39,421 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $1,502,060 | 38,357 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $1,028,316 | 28,383 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $808,310 | 21,959 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $734,769 | 20,021 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $658,644 | 20,142 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||